375 related articles for article (PubMed ID: 32215665)
1. Interleukin 23 and autoimmune diseases: current and possible future therapies.
Abdo AIK; Tye GJ
Inflamm Res; 2020 May; 69(5):463-480. PubMed ID: 32215665
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-23: as a drug target for autoimmune inflammatory diseases.
Tang C; Chen S; Qian H; Huang W
Immunology; 2012 Feb; 135(2):112-24. PubMed ID: 22044352
[TBL] [Abstract][Full Text] [Related]
3. Targeting IL-17 and IL-23 in Immune Mediated Renal Disease.
Ghali JR; Holdsworth SR; Kitching AR
Curr Med Chem; 2015; 22(38):4341-65. PubMed ID: 26521930
[TBL] [Abstract][Full Text] [Related]
4. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
[TBL] [Abstract][Full Text] [Related]
5. The IL23/Th17 pathway as a therapeutic target in chronic inflammatory diseases.
Toussirot E
Inflamm Allergy Drug Targets; 2012 Apr; 11(2):159-68. PubMed ID: 22280236
[TBL] [Abstract][Full Text] [Related]
6. Targeting Th17 cells in autoimmune diseases.
Yang J; Sundrud MS; Skepner J; Yamagata T
Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
[TBL] [Abstract][Full Text] [Related]
7. IL-38: A New Player in Inflammatory Autoimmune Disorders.
Xie L; Huang Z; Li H; Liu X; Zheng S; Su W
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31387327
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of IL-35 in inflammatory autoimmune diseases.
Su LC; Liu XY; Huang AF; Xu WD
Autoimmun Rev; 2018 Jul; 17(7):665-673. PubMed ID: 29729445
[TBL] [Abstract][Full Text] [Related]
9. Insights into IL-37, the role in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Autoimmun Rev; 2015 Dec; 14(12):1170-5. PubMed ID: 26264940
[TBL] [Abstract][Full Text] [Related]
10. Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders.
Gooderham MJ; Papp KA; Lynde CW
J Eur Acad Dermatol Venereol; 2018 Jul; 32(7):1111-1119. PubMed ID: 29438576
[TBL] [Abstract][Full Text] [Related]
11. Targeting Interleukin-23 in the Treatment of Noninfectious Uveitis.
Pepple KL; Lin P
Ophthalmology; 2018 Dec; 125(12):1977-1983. PubMed ID: 30458922
[TBL] [Abstract][Full Text] [Related]
12. New insights into the IL-12 and IL-23: From a molecular basis to clinical application in immune-mediated inflammation and cancers.
Chyuan IT; Lai JH
Biochem Pharmacol; 2020 May; 175():113928. PubMed ID: 32217101
[TBL] [Abstract][Full Text] [Related]
13. Protective role of R381Q (rs11209026) polymorphism in IL-23R gene in immune-mediated diseases: A comprehensive review.
Abdollahi E; Tavasolian F; Momtazi-Borojeni AA; Samadi M; Rafatpanah H
J Immunotoxicol; 2016 May; 13(3):286-300. PubMed ID: 27043356
[TBL] [Abstract][Full Text] [Related]
14. Targeting the IL-23/IL-17 axis for the treatment of psoriasis and psoriatic arthritis.
Alunno A; Carubbi F; Cafaro G; Pucci G; Battista F; Bartoloni E; Giacomelli R; Schillaci G; Gerli R
Expert Opin Biol Ther; 2015; 15(12):1727-37. PubMed ID: 26653110
[TBL] [Abstract][Full Text] [Related]
15. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
Leng RX; Pan HF; Tao JH; Ye DQ
Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
[TBL] [Abstract][Full Text] [Related]
16. Specific targeting of the IL-23 receptor, using a novel small peptide noncompetitive antagonist, decreases the inflammatory response.
Quiniou C; DomÃnguez-Punaro M; Cloutier F; Erfani A; Ennaciri J; Sivanesan D; Sanchez M; Chognard G; Hou X; Rivera JC; Beauchamp C; Charron G; Vilquin M; Kuchroo V; Michnick S; Rioux JD; Lesage S; Chemtob S
Am J Physiol Regul Integr Comp Physiol; 2014 Nov; 307(10):R1216-30. PubMed ID: 25354400
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-23: A New Atherosclerosis Target.
Liu W; Chang C; Hu H; Yang H
J Interferon Cytokine Res; 2018 Oct; 38(10):440-444. PubMed ID: 30328797
[TBL] [Abstract][Full Text] [Related]
18. Insights into IL-23 biology: From structure to function.
Floss DM; Schröder J; Franke M; Scheller J
Cytokine Growth Factor Rev; 2015 Oct; 26(5):569-78. PubMed ID: 26195433
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the IL-23/IL-17 axis and the Th17/Treg balance in the pathogenesis and control of autoimmune arthritis.
Astry B; Venkatesha SH; Moudgil KD
Cytokine; 2015 Jul; 74(1):54-61. PubMed ID: 25595306
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-23: immunological roles and clinical implications.
Tan ZY; Bealgey KW; Fang Y; Gong YM; Bao S
Int J Biochem Cell Biol; 2009 Apr; 41(4):733-5. PubMed ID: 18725317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
